ٍٍSofosbuvir/Simeprevir/Daclatasvir/Ribavirin and HCV Genotype 4-infected Egyptian Experienced Participants
NCT04387539
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
94
Enrollment
OTHER
Sponsor class
Conditions
Chronic Hepatitis C Virus Infection
Interventions
DRUG:
SOF/SMV/DCV/RBV
Sponsor
Beni-Suef University